A rare and fatal case of HIV-related toxoplasmosis infection reveals the diagnostic challenges and the need for heightened clinical vigilance. But is it a preventable tragedy? The Battle Against a Tiny Invader
Toxoplasmosis, caused by the cunning parasite Toxoplasma gondii, is a global infection affecting around one-third of the population, with rates varying by location, socioeconomic factors, and diet.1,2 Ghana holds the record for the highest prevalence, with a recent meta-analysis estimating a global seroprevalence of 31%.1 An earlier Lancet study found that 35.8% of people living with HIV (PLHIV) were infected, with 87.1% of cases in sub-Saharan Africa (SSA).2
Cats are the primary hosts, but humans often become infected by eating undercooked meat from other infected animals. The immune system's response determines the infection's severity. In healthy individuals, toxoplasmosis may cause mild flu-like symptoms or none at all. However, in immunocompromised patients, especially those with advanced HIV/AIDS, it can be life-threatening due to reactivation and severe symptoms, typically with CD4 counts below 100 cells/μL.
The Many Faces of Toxoplasmosis
Toxoplasmosis typically manifests as cerebral toxoplasmosis, causing neurological deficits, seizures, and brain lesions.4,5 It's a leading cause of neurological complications and morbidity among PLHIV, especially in resource-limited settings where early diagnosis and prophylaxis are challenging.6 Cardiac toxoplasmosis, on the other hand, is rare and often goes unnoticed due to nonspecific symptoms, lack of clinical suspicion, and absent radiological signs.7 Cardiac involvement can lead to myocarditis, pericarditis, and severe complications like heart failure and arrhythmias, further complicating the picture.7,8
A Complex Clinical Scenario
Simultaneous cerebral and cardiac toxoplasmosis is extremely rare, and documented cases are scarce.3,8,9 This case report presents a unique scenario: a newly diagnosed HIV patient, initially treated for severe malaria, rapidly deteriorated and died. Autopsy revealed concurrent cerebral and cardiac toxoplasmosis, emphasizing the diagnostic complexity and the need for prompt action.
The Patient's Journey
A 50-year-old male HIV patient with a low CD4+ count of 25 cells/µL presented with severe headaches and nausea. He had a history of alcoholism and hypertension, with poor adherence to antihypertensive medication. Initial management included diclofenac, IV antibiotics, and fluid resuscitation. He was started on antiretroviral therapy (TLD) and prophylactic co-trimoxazole.
Laboratory tests for cryptococcal antigen and Lipoarabinomannan (LAM) were negative, but a malaria rapid diagnostic test (MRDT) was positive. Intravenous artesunate was administered, but the patient left the facility without medical knowledge. The next day, he returned in a severely deteriorated state, suspected of alcohol intoxication. He exhibited vomiting, tremors, and seizures, with a drop in consciousness.
Despite resuscitation efforts, the patient's condition worsened, leading to cardiac arrest and death. Autopsy findings confirmed cerebral and cardiac toxoplasmosis, with extensive brain and heart lesions.
Unraveling the Mystery
Microscopic examination of the brain and heart revealed extensive necrosis, inflammation, and the presence of Toxoplasma gondii parasites. Definitive diagnosis of T. gondii infection involves clinical evaluation, laboratory tests, and histopathology. Serological tests, ELISA, and IFAT are crucial for detecting anti-toxoplasma antibodies. Molecular techniques like PCR are invaluable, especially in immunocompromised patients. Histopathology confirms active disease by identifying bradyzoites or tachyzoites in tissue biopsies.
Treatment and Prevention
Standard therapy for cerebral and systemic toxoplasmosis includes pyrimethamine, sulfadiazine, and leucovorin. Alternative therapies are used for intolerance or hypersensitivity. For HIV-positive patients, antiretroviral therapy (ART) is essential. Secondary prophylaxis is indicated until sustained immune recovery. In this case, the initial misdiagnosis as severe malaria highlights the need for heightened suspicion in HIV patients with neurological and atypical symptoms.
Learning from Limitations
The study faced limitations, including the unavailability of immunohistochemical stains and the absence of diagnostic imaging and blood tests. However, the H&E stain confirmed the diagnosis. This case underscores the importance of early and accurate diagnosis, comprehensive evaluations, and the role of autopsy in HIV patients with complex syndromes.
Controversy and Comment
Could this tragic outcome have been prevented? The patient's non-compliance and escape from the facility complicated management. But was the initial misdiagnosis as malaria a missed opportunity? In resource-limited settings, the challenge of diagnosing toxoplasmosis is evident. How can we improve diagnostic accuracy and ensure timely referrals? Share your thoughts and experiences in the comments, and let's explore ways to enhance clinical practice in the battle against toxoplasmosis.
